- Free from Publisher MC Carr, RH Knopp, JD Brunzell, BS … - Diabetes care, 2005 - Am Diabetes Assoc RESULTS—At week 2 of the study, three (25%) of the subjects withdrew from the
trial because they developed marked hypertriglyceridemia (≥11.3 mmol/l
[≥1,000 mg/dl]) during raloxifene therapy. These three women had higher ... Cited by 4 - Related articles - BL Direct - All 7 versions
S Sasaki - Kidney international, 2006 - ncbi.nlm.nih.gov 1: Kidney Int. 2006 May;69(9):1485-6. Nephrologists Sans Frontières: chronic
kidney disease in Japan. Sasaki S. Publication Types ... Cited by 2 - Related articles - BL Direct - All 3 versions
[CITATION] Bruckner. How to assess glomerular function and damage in humans
MW Draper, L Plouffe Jr - Obstetrics & Gynecology, 2005 - journals.lww.com To the Editor: We read with interest the decision anal- ysis model developed by
Parker et al1 regarding ovarian conservation at the time of hysterectomy for
benign dis- ease. The previous model developed by Armstrong et al2 ... Cited by 2 - Related articles - All 4 versions
[CITATION] Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4- …
JA Cauley, L Norton, ME Lippman, S Eckert, … - Breast Cancer Res Treat, 2001 Cited by 2 - Related articles
[CITATION] Raloxifene reduces macrophage accumulation and matrix metalloproteinase expression in …
TD Dayspring - The journal of gender-specific medicine: JGSM: the … - ncbi.nlm.nih.gov An examination of coronary heart disease in women over the past two decades in
the United States reveals a disturbing gender difference that points to more
treatment success in men than in women, which raises the question as to ... Cited by 3 - Related articles - All 3 versions
